Aripiprazole for Prevention of Relapse to Cocaine Use in Methadone-Maintenance Patients
|ClinicalTrials.gov Identifier: NCT00780702|
Recruitment Status : Completed
First Posted : October 28, 2008
Last Update Posted : April 17, 2018
National Institute on Drug Abuse (NIDA)
Information provided by:
National Institutes of Health Clinical Center (CC)
No Study Results Posted on ClinicalTrials.gov for this Study
|Recruitment Status :||Completed|
|Actual Primary Completion Date :||April 16, 2013|
|Actual Study Completion Date :||April 16, 2013|
Bjornsson TD, Callaghan JT, Einolf HJ, Fischer V, Gan L, Grimm S, Kao J, King SP, Miwa G, Ni L, Kumar G, McLeod J, Obach SR, Roberts S, Roe A, Shah A, Snikeris F, Sullivan JT, Tweedie D, Vega JM, Walsh J, Wrighton SA; Pharmaceutical Research and Manufacturers of America Drug Metabolism/Clinical Pharmacology Technical Working Groups. The conduct of in vitro and in vivo drug-drug interaction studies: a PhRMA perspective. J Clin Pharmacol. 2003 May;43(5):443-69. Review.
Childress AR, O'Brien CP. Dopamine receptor partial agonists could address the duality of cocaine craving. Trends Pharmacol Sci. 2000 Jan;21(1):6-9. Review.